CRIVELLARO, CINZIA
 Distribuzione geografica
Continente #
NA - Nord America 6.225
EU - Europa 3.547
AS - Asia 1.539
SA - Sud America 161
AF - Africa 21
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 12
Totale 11.525
Nazione #
US - Stati Uniti d'America 6.120
IT - Italia 1.084
SG - Singapore 584
DE - Germania 535
CN - Cina 534
RU - Federazione Russa 439
SE - Svezia 397
IE - Irlanda 310
HK - Hong Kong 185
UA - Ucraina 182
GB - Regno Unito 141
BR - Brasile 140
AT - Austria 103
CA - Canada 97
FR - Francia 74
DK - Danimarca 62
FI - Finlandia 60
VN - Vietnam 57
IN - India 51
NL - Olanda 33
TR - Turchia 31
BE - Belgio 26
ID - Indonesia 25
CZ - Repubblica Ceca 21
PL - Polonia 21
AU - Australia 19
CH - Svizzera 16
ES - Italia 14
BG - Bulgaria 10
KR - Corea 10
EU - Europa 7
IR - Iran 7
JP - Giappone 7
AR - Argentina 5
IQ - Iraq 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AZ - Azerbaigian 4
BD - Bangladesh 4
MX - Messico 4
PT - Portogallo 4
RO - Romania 4
SC - Seychelles 4
TW - Taiwan 4
ZA - Sudafrica 4
BO - Bolivia 3
CL - Cile 3
EC - Ecuador 3
EG - Egitto 3
GE - Georgia 3
HU - Ungheria 3
KZ - Kazakistan 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
MA - Marocco 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
GR - Grecia 2
JO - Giordania 2
KE - Kenya 2
MD - Moldavia 2
PH - Filippine 2
PK - Pakistan 2
PY - Paraguay 2
TN - Tunisia 2
UZ - Uzbekistan 2
CO - Colombia 1
CR - Costa Rica 1
DZ - Algeria 1
EE - Estonia 1
GA - Gabon 1
HN - Honduras 1
IL - Israele 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
LB - Libano 1
LU - Lussemburgo 1
MK - Macedonia 1
MN - Mongolia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PE - Perù 1
SA - Arabia Saudita 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 11.525
Città #
Ann Arbor 1.578
Chandler 466
Fairfield 454
Woodbridge 415
Singapore 385
Frankfurt am Main 366
Wilmington 357
Houston 328
Milan 328
Ashburn 316
Dublin 297
Dearborn 234
Seattle 187
Hong Kong 169
Jacksonville 169
Cambridge 161
Santa Clara 157
New York 156
Princeton 111
Shanghai 103
Lissone 100
Vienna 94
Nanjing 86
Altamura 51
Lawrence 49
Fremont 38
Monza 37
Guangzhou 35
Boardman 33
San Diego 32
Beijing 31
Ottawa 31
Council Bluffs 30
Nanchang 29
Helsinki 27
Lachine 27
Falls Church 26
London 26
Jakarta 25
Moscow 23
Brussels 21
Dong Ket 21
Shenyang 21
Rome 20
Andover 18
Kunming 18
Brno 17
Hangzhou 17
Jinan 17
Ningbo 17
Toronto 17
Dallas 16
Los Angeles 15
Munich 15
Nuremberg 15
Pune 15
Tianjin 15
Genoa 14
Edmonton 13
São Paulo 13
Kraków 12
Melbourne 12
Changsha 11
Hebei 11
Norwalk 11
Segrate 11
Amsterdam 10
Lanzhou 10
Lauterbourg 10
Bari 9
Detroit 9
Hefei 9
Jiaxing 9
Kiev 9
Düsseldorf 8
Kocaeli 8
Mountain View 8
Plovdiv 8
Zhengzhou 8
Biella 7
Como 7
Lecco 7
Newark 7
Paris 7
Bologna 6
Carate Brianza 6
Chicago 6
Fort Myers 6
Huizen 6
Leawood 6
Madrid 6
Sesto San Giovanni 6
Vadodara 6
Verdellino 6
Alessandria 5
Catania 5
Porto Alegre 5
San Mateo 5
Taizhou 5
Washington 5
Totale 8.210
Nome #
Treatment response assessment in [18F]FDG-PET/CT oncology scans: Impact of count statistics variation and reconstruction protocol 403
Radiomics of the primary tumour as a tool to improve 18F-FDG-PET sensitivity in detecting nodal metastases in endometrial cancer 335
18F-FDG PET/CT in a Case of Metastatic Breast Cancer to the Vulva 334
A Metabolic Imaging Study of Lexical and Phonological Naming Errors in Alzheimer Disease 332
18F-FDG-PET/CT guiding to diagnosis of neurosarcoidosis 328
Cognitive reserve maps the core loci of neurodegeneration in corticobasal degeneration 326
Added diagnostic value of respiratory-gated 4D 18F–FDG PET/CT in the detection of liver lesions: a multicenter study 317
Combining positron emission tomography/computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients 302
Role of 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in malignant ovarian germ cell tumors: a single-center experience with long term follow-up 284
Cardiotoxicity in breast cancer patients: the role of gated myocardial perfusion SPECT 260
Anatomical correlates of reading in the elderly brain: an FDG-PET analysis of the reading performance in Alzheimer's Disease 252
18F-FDG PET/CT in preoperative staging of vulvar cancer patients: Is it really effective? 243
Staging of High-Risk Endometrial Cancer With PET/CT and Sentinel Lymph Node Mapping 240
Sentinel node biopsy in endometrial cancer: an update 237
Motion management in PET/CT: Technological solutions 231
Quality of Care for Cervical and Endometrial Cancer Patients: The Impact of Different Techniques of Sentinel Lymph Node Mapping on Patient Satisfaction 225
Sentinel-node mapping in endometrial cancer patients: comparing SPECT/CT, gamma-probe and dye 224
Respiratory motion management in PET/CT: applications and clinical usefulness 224
From Conventional Radiotracer Tc-99m with Blue Dye to Indocyanine Green Fluorescence: A Comparison of Methods Towards Optimization of Sentinel Lymph Node Mapping in Early Stage Cervical Cancer for a Laparoscopic Approach 224
18F-FDG PET/CT can predict nodal metastases but not recurrence in early stage uterine cervical cancer 222
Predictive value of 18F-FDG PET/CT in restaging patients affected by ovarian carcinoma: a multicentre study 212
Impact of Indocyanine Green for Sentinel Lymph Node Mapping in Early Stage Endometrial and Cervical Cancer: Comparison with Conventional Radiotracer 99mTc and/or Blue Dye 209
Role of PET/CT in the clinical management of locally advanced pancreatic cancer 202
Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer: the role of 18F-FDG PET/CT 200
Preoperative 18F-FDG PET/CT in the management of advanced epithelial ovarian cancer 200
Preoperative staging of cervical cancer: is 18-FDG-PET/CT really effective in patients with early stage disease? 199
Temporal lobe dysfunction in late-onset epilepsy of unknown origin 198
Detection of nodal metastases by 18F-FDG PET/CT in apparent early stage ovarian cancer: a prospective study 194
11C-choline PET/CT as a guide to radiation treatment planning of lymph-node relapses in prostate cancer patients 191
The "digital biopsy" in non-small cell lung cancer (NSCLC): a pilot study to predict the PD-L1 status from radiomics features of [18F]FDG PET/CT 191
The heterogeneity of lung perfusion patterns in SPECT/CT during COVID-19: not only embolism 189
Intrathoracic splenosis: Evaluation by 99mTc-labelled heat-denatured erythrocyte SPECT/CT 186
Unusual presentation of sarcoid-like reaction on bone marrow level associated with mediastinal lymphadenopathy on 18F-FDG-PET/CT resembling an early recurrence of Hodgkin's Lymphoma 183
Comparative analysis of iterative reconstruction algorithms with resolution recovery for cardiac SPECT studies. A multi-center phantom study 182
Focal bone lesions in hiv-positive patient treated with tenofovir 180
[(11)C]Choline PET/CT detection of bone metastases in patients with PSA progression after primary treatment for prostate cancer: comparison with bone scintigraphy 174
Integrated PET/CT as a first-line re-staging modality in patients with suspected recurrence of ovarian cancer 162
Metabolic parameters as biomarkers of response to immunotherapy and prognosis in non-small cell lung cancer (Nsclc): A real world experience 160
Baseline 18FDG-PET Metabolic Tumour Volume (MTV) as a Potential Predictive Factor of Response to Metronomic Chemotherapy (mCHT) in HR+/HER2- Metastatic Breast Cancer (MBC) Patients (pts). Preliminary Results of the Metro-pet Study 158
Indocyanine Green versus Radiotracer with or without Blue Dye for Sentinel Lymph Node Mapping in Stage >IB1 Cervical Cancer (>2 cm) 149
Contained rupture of common iliac artery aneurysm in a contrast-enhanced PET/CT study 140
Clinical evidence on PET/CT for radiation therapy planning in prostate cancer 139
Assessment of nodal status by 18F-FDG PET/CT in early stage ovarian cancer 138
Validity of cingulate–precuneus–temporo-parietal hypometabolism for single-subject diagnosis of biomarker-proven atypical variants of Alzheimer’s Disease 138
PET/CT and contrast enhanced CT in single vs. two separate sessions: a cost analysis study 136
Real-Time Fluorescent Sentinel Lymph Node Mapping with Indocyanine Green in Women with Previous Conization Undergoing Laparoscopic Surgery for Early Invasive Cervical Cancer: Comparison with Radiotracer ± Blue Dye 135
PET-CT for treatment planning in prostate cancer 133
Comment on 'Pre-operative nomogram for the identification of lymph node metastasis in early cervical cancer' 129
An optimized protocol for correlation of PET-FDG and pCASL data in mild cognitive impairment (MCI) patients 123
Molecular imaging in prostate cancer: [11C]choline PET/CT 119
Clinical Application of a High Sensitivity BGO PET/CT Scanner: Effects of Acquisition Protocols and Reconstruction Parameters on Lesions Quantification 118
Clinical and metabolic imaging features of late-onset and early-onset Posterior Cortical Atrophy 108
Clinical applicability of pCASL as a substitute for FDG-PET in the etiological diagnosis of MCI and SCD: CAPE study protocol 107
Respiratory Gating and the performance of PET/CT in pulmonary lesions 106
Performance of a SPECT collimator-detector response reconstruction algorithm: phantom studies and validation in inflammation clinical studies 105
Validation of brain 18FDG-PET and pCASL joint analysis tool: a ROI-based approach 102
Learning From Mistakes: Cognitive and Metabolic Correlates of Errors on Picture Naming in the Alzheimer's Disease Spectrum 91
Depressive Pseudodementia with Reversible AD-like Brain Hypometabolism: A Case Report and a Review of the Literature 90
PET-Guided target delineation in a patient with lung cancer. 78
Cervical injection for sentinel lymph nodes detection in endometrial cancers is controversial: response to comments 75
Clinical and neuroimaging characterization of the first frontotemporal dementia family carrying the MAPT p.K298E mutation 72
Left and right corticobasal syndrome: comparison of cognitive profiles between metabolic imaging - matched groups 59
A ROI-based quantitative pipeline for 18F-FDG PET metabolism and pCASL perfusion joint analysis: Validation of the 18F-FDG PET line 57
Reduced phonemic fluency in progressive supranuclear palsy is due to dysfunction of dominant BA6 56
A ROI-based quantitative pipeline for 18F-FDG PET metabolism and pCASL perfusion joint analysis: validation on 18F-FDG PET data 53
A cognitive marker for Alzheimer disease pathology in primary progressive aphasia? A validation study in the clinical setting 50
Metabolic subtypes of Posterior Cortical Atrophy: a data-driven approach controlling for pathophysiology-related hypometabolism 37
Cognitive profile of right and left Corticobasal Syndrome 25
Neurocognitive heterogeneity of Posterior Cortical Atrophy 25
Mapping category fluency to the ventral and dorsal language streams in PCA and semantic and logopenic PPA 23
Cognitive profile and metabolic brain imaging in late-onset PCA compared with early-onset PCA and senile amnesic AD 22
Guidelines for the screening and follow-up of infants born to anti-HCV positive mothers 19
Totale 12.070
Categoria #
all - tutte 41.561
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.561


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020283 0 0 0 0 0 0 0 0 0 105 138 40
2020/20211.781 56 73 187 183 163 183 147 180 142 156 141 170
2021/20221.107 107 140 110 116 64 71 56 54 53 92 99 145
2022/20231.834 182 531 152 219 112 281 13 108 97 45 53 41
2023/20241.307 53 54 74 77 140 294 235 70 67 38 21 184
2024/20252.196 155 334 169 136 207 181 236 112 273 393 0 0
Totale 12.070